5 results about "Cerebral arteriosclerosis" patented technology

The invention relates to granules for promoting blood circulation to remove meridian obstruction and a preparation method thereof. Ginkgo leaves, fried spina date seeds, astragalus membranaceus, radix puerariae, hawthorn, salvia miltiorrhiza, allium macrostemon, rhodiola rosea, fructus lycii, acanthopanax, schisandra chinensis and radix ophiopogonis are selected as raw materials, the raw materials are decocted, filtered, concentrated and granulated, the materials are all selected from natural traditional Chinese medicine components, the effects of promoting blood circulation to remove blood stasis and activating meridians to stop pain are achieved, and the traditional Chinese medicine composition has a remarkable curative effect on chest stuffiness, cardiodynia, dizziness, coronary heart disease and angina pectoris caused by blood stasis blocking collaterals. The traditional Chinese medicine composition has obvious curative effects on symptoms such as hypertension, hyperlipidemia and cerebral arteriosclerosis, has no side effect on the body, is simple in preparation method and low in production cost, and has application and popularization prospects.

The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine formula for treating primary hypertension. The traditional Chinese medicine formula for treating primary hypertension comprises the following components in parts by weight: 10-15 parts of angelica sinensis; 10 to 15 parts of radix rehmanniae; 5-10 parts of Chinese herbaceous peony; 15 to 20 parts of radix puerariae; 5 to 10 parts of fructus gardeniae; 3-7 parts of coptis chinensis; 5-10 parts of radix scutellariae; 10 to 15 parts of hawthorn; 10-15 parts of eucommia ulmoides; 3-6 parts of fritillary bulb; 2-6 parts of radix aucklandiae; 4-9 parts of polygala tenuifolia; 1-4 parts of rhizoma cyperi; 3-7 parts of earthworm; 5-10 parts of radix astragali; 5-10 parts of motherwort herb; 1-2 parts of herba siegesbeckiae; and 1-2 parts of apocynum venetum. The traditional Chinese medicine formula for treating primary hypertension provided by the invention has the effects of treating primary hypertension, Meniere's syndrome, cerebral arteriosclerosis, vertebrobasilar artery insufficiency, nervous tinnitus and neurasthenia; the traditional Chinese medicine composition is remarkable in antihypertensive effect, safe and free of side effects.

The present invention provides a non-invasive cerebral artery stiffness detection system, including: an ultrasonic Doppler module for transmitting pulsed ultrasonic Doppler signals to the common carotid artery and the terminal of the internal carotid artery of a user, and collecting ultrasonic Doppler signals reflected from the common carotid artery and the terminal of the internal carotid artery; a signal processing module for pre-processing the two collected ultrasonic Doppler signals respectively, and obtaining two blood flow waveform data through FFT transformation; a signal analysis module for calculating the pulse wave velocity of the cervical and cerebral arteries based on the distance between the common carotid artery and the terminal of the internal carotid artery of the user using the waveform time difference of the two blood flow waveform data, and determining the cerebral artery stiffness of the user according to a preset pulse wave velocity-cerebral artery stiffness comparison table. The present invention can simply, easily and accurately measure the cervical and cerebral pulse wave velocity, evaluate the condition of cervical and cerebral arteriosclerosis, and provide effective help for the clinical diagnosis and treatment of cerebrovascular diseases by medical staff.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and discloses a TCM composition, preparation method, and oral formulation for treating cardiovascular and cerebrovascular diseases of the Qi deficiency and blood stasis type. The TCM composition is made from kudzu root, astragalus root, notoginseng, safflower, chuanxiong rhizome, hawthorn, angelica root, polygonum cuspidatum, licorice root, and salvia miltiorrhiza in specific weight parts. A preferred ratio is 60 parts kudzu root, 60 parts astragalus root, 25 parts notoginseng, 30 parts safflower, 25 parts chuanxiong rhizome, 30 parts hawthorn, 25 parts angelica root, 25 parts polygonum cuspidatum, 10 parts licorice root, and 26 parts salvia miltiorrhiza. It can be used for coronary heart disease, cerebral arteriosclerosis, cerebral thrombosis, hyperlipidemia, or sequelae of cerebral infarction. In preparation, the medicinal materials are cleaned, dried, mixed, and pulverized into a fine powder, passed through a 120-180 mesh sieve, and then formed into water pills using water as a binder. After drying and packaging, the product is obtained. This invention has a scientific formulation and precise proportions, making it suitable for the long-term prevention and treatment of cardiovascular and cerebrovascular diseases of the Qi deficiency and blood stasis type.

The present invention provides a pharmaceutical composition containing ticagrelor for use in reducing or preventing thromboembolic events before and / or during and / or after neurovascular arterial procedures in a patient requiring the use of the pharmaceutical composition containing ticagrelor, comprising administering an effective amount of the pharmaceutical composition containing ticagrelor to a patient, wherein the pharmaceutical composition is an aqueous solution containing a solubilizing agent for ticagrelor and the pharmaceutical composition is administered intravenously; wherein the patient suffers from a cerebral aneurysm, cerebral arteriosclerosis, cervical arteriosclerosis, neurovascular carotid dissection or carotid dissection.